Archives
Unvaccinated, unmasked teacher infected more than half of students in class with Covid-19, CDC reports.
29 Aug, 2021 | 18:52h | UTC
#ESCCongress – 2021 ESC/EACTS Guidelines for the management of valvular heart disease – in the new guidelines, more patients are eligible for surgical and transcatheter interventions, based not only on symptoms but also on imaging criteria.
29 Aug, 2021 | 18:23h | UTCNews release: European valvular heart disease Guidelines published today – European Society of Cardiology
Summary: 2021 ESC/EACTS Valvular Heart Disease Guidelines: Key Points – American College of Cardiology
Commentary: Revamped Valve Disease Guideline: Europe Sees Nearly Eye to Eye With U.S. – MedPage Today (free registration required)
“In line with recent U.S. recommendations, the newest European guidelines favor a wider pool of patients eligible for surgical and transcatheter interventions for valvular heart disease.” (from MedPage Today)
Commentaries on Twitter
#ESCCongress new VHD guidelines out ➡️https://t.co/fFkuivAM9E
➡️SAVR in low risk pts <75yrs old
➡️ TAVR in pts >75
➡️ Role of heart team emphasised
➡️ NEW! intervention to be considered with asymptomatic AS with lv <55% IIa@HanCardiomd @Hragy @aayshacader @DrMarthaGulati #TAVR pic.twitter.com/JV1zocQJaK— Mamas A. Mamas (@mmamas1973) August 28, 2021
🆕Guidelines for the management of valvular heart disease #ESCCongress @escardio @secardiologia @EACTS
📂 https://t.co/3FCS8YYKIr @mmamas1973 @shci_sec pic.twitter.com/wxuf3AjVaE
— Alfonso Valle (@ValleAlfonso) August 28, 2021
Optimal antithrombotic therapy for valve prostheses from the 2021 #ESC Guidelines for the management of VHD #ESCCongress @escardio https://t.co/AmQJkZBMoo pic.twitter.com/WK2wQSSlhL
— Dr Roxana Mehran (@Drroxmehran) August 28, 2021
(thread – click for more)
Have there been changes in when to intervene with the new 2021 ESC/EACTS guidelines for the management of valvular heart disease?
Yes, and in general the bar for intervention is now lower
Thread follows…#ESCCongress
1/n pic.twitter.com/iLN9cLCtLj
— Sarah Hudson (@sarahhudsonuk) August 28, 2021
M-A: Factors associated with household transmission of SARS-CoV-2 – recent studies showed higher household secondary attack rates than earliest reports (13.4% vs. 31.1%); more transmissible variants and vaccines may lead to further changes.
29 Aug, 2021 | 18:48h | UTCCommentary: 1 in 5 people with COVID-19 pass it to others in household, study finds – UPI
Commentary on Twitter
The findings of this meta-analysis suggest that the household remains an important site of #SARSCoV2 transmission, and recent studies have higher household secondary attack rates estimates compared with the earliest reports. https://t.co/lFmkaz0zUe
— JAMA Network Open (@JAMANetworkOpen) August 27, 2021
New CDC Guidance says influenza and Covid vaccines can be given together – “COVID-19 vaccines and other vaccines may now be administered without regard to timing”
29 Aug, 2021 | 18:51h | UTCCommentary: Flu shot and a COVID jab? New 2021-2022 flu vaccine guidance points to both – McKnight’s
#ESCCongress – 2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy.
29 Aug, 2021 | 18:20h | UTCNews release: ESC Guidelines on cardiac pacing and cardiac resynchronisation therapy launched today – European Society of Cardiology
Commentary on Twitter
NEW: #ESCGuidelines on cardiac pacing and cardiac resynchronisation therapy https://t.co/aJTDQyv5Fz#cardiotwitter #EPeeps #medtwitter pic.twitter.com/GPJt9yRWTn
— European Society of Cardiology (@escardio) August 29, 2021
#ESCCongress – 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure – SGLT2 inhibitors are now recommended for patients with heart failure with reduced ejection fraction regardless of the presence of diabetes.
29 Aug, 2021 | 18:25h | UTCNews release: ESC Guidelines on heart failure management launched today – European Society of Cardiology
Commentary on Twitter
The new heart failure guidelines by @escardio https://t.co/NRvxh8UUxp ready for #ESCCongress https://t.co/NlGYM9DAqA enjoy reading 128 pages. Some important figures pic.twitter.com/6GmRUuSw9z
— rafavidalperez (@rafavidalperez) August 27, 2021
#ESCCongress – Cluster RCT: Among patients at increased risk for stroke, salt substitution (75% sodium chloride and 25% potassium chloride by mass) reduced the rates of stroke, major cardiovascular events, and death from any cause.
29 Aug, 2021 | 19:21h | UTCEffect of Salt Substitution on Cardiovascular Events and Death – New England Journal of Medicine (link to abstract – $ for full-text)
News release: Low-sodium salt prevents stroke – European Society of Cardiology
Commentary: Massive SSaSS Study Shows Switch to Salt Substitute Cuts Stroke, CVD – TCTMD
Commentary on Twitter
SSaSS: In RCT that compared salt substitute w/ regular salt, rates of stroke, major CV events, death lower with salt sub. #ESCCongress https://t.co/Yt6vMrYSDh pic.twitter.com/jtymS36zqs
— NEJM (@NEJM) August 29, 2021
#ESCCongress – RCT: SGLT2 inhibition reduced the combined risk of cardiovascular death or hospitalization in patients with heart failure and a preserved ejection fraction, regardless of the presence or absence of diabetes.
29 Aug, 2021 | 18:19h | UTCEmpagliflozin in Heart Failure with a Preserved Ejection Fraction – New England Journal of Medicine
News release: Trial reports first successful results for heart failure with preserved ejection fraction – European Society of Cardiology
Commentary on Twitter
#FIGARO-DKD #ESCCongress
🔺in patients w T2D & microalbuminuria & stage 1-4 CKD, finerenone vs placebo led to 13% relative ⬇️in CV events (mostly due to 29%⬇️in HF hospitalizations)
🔺~2/3 pts +microalbuminuria w normal GFR:🔑 is to✔️in T2D#ESCCongress https://t.co/8oT5s8KjT0 pic.twitter.com/fQbmUzPasD— Ritu Thamman MD (@iamritu) August 28, 2021
#ESCCongress – RCT: In patients with A. Fibrillation who underwent TAVR, Edoxaban was noninferior to Vit. K Antagonist regarding the composite primary outcome of adverse clinical events, but resulted in a higher incidence of major bleeding.
29 Aug, 2021 | 18:17h | UTCCommentaries:
ENVISAGE-TAVI AF: Edoxaban Disappoints in TAVI Setting – TCTMD
#ESCCongress – RCT: In patients who underwent PCI at high bleeding risk, 1 month of dual antiplatelet therapy was noninferior to the continuation of dual therapy for at least 2 additional months and resulted in a lower incidence of bleeding events.
29 Aug, 2021 | 18:16h | UTCCommentaries:
#ESCCongress – RCT: Immediate coronary angiography after out-of-hospital cardiac arrest without ST-segment elevation did not improve outcomes compared to delayed/selective angiography.
29 Aug, 2021 | 18:12h | UTCNews release: Trial does not support early coronary angiography in cardiac arrest without ST elevation – European Society of Cardiology
Commentaries:
Commentary on Twitter
TOMAHAWK: In patients without ST elevation and OHCA, immediate coronary angiography provided no benefit over delayed. #ESCCongress https://t.co/7IKJ1y4B8v pic.twitter.com/H0cyyl18ig
— NEJM (@NEJM) August 29, 2021
#ESCCongress – RCT: Finerenone reduced CV events in patients with kidney disease and type 2 diabetes (12.4% vs. 14.2% during a median follow-up of 3.4 years), but the risk of hyperkalemia was increased (10.8% vs. 5.3%).
29 Aug, 2021 | 18:14h | UTCNews release: Finerenone benefits patients with diabetes across spectrum of kidney disease – European Society of Cardiology
Commentaries:
Related:
Commentary on Twitter
FIGARO-DKD: Among patients with stage 1 to 4 CKD and T2 diabetes, finerenone improved CV outcomes as compared with placebo. #ESCCongress https://t.co/mcfmvftBvy pic.twitter.com/qizit80NBa
— NEJM (@NEJM) August 28, 2021
#ESCCongress – RCT: Initial hypertension treatment with a single pill with 4 drugs at quarter doses (irbesartan 37.5 mg, amlodipine 1.25 mg, indapamide 0.625 mg, and bisoprolol 2.5 mg) achieved better BP lowering vs. standard monotherapy (irbesartan 150 mg).
29 Aug, 2021 | 18:11h | UTCInitial treatment with a single pill containing quadruple combination of quarter doses of blood pressure medicines versus standard dose monotherapy in patients with hypertension (QUARTET): a phase 3, randomised, double-blind, active-controlled trial – The Lancet (link to abstract – $ for full-text)
Commentary: Quadruple UltrA-low-dose tReaTment for hypErTension – QUARTET – American College of Cardiology
#ESCCongress – RCT: Among asymptomatic patients with severe carotid stenosis, carotid surgery and stenting carry similar risks, and the long-term risk of stroke was comparable. There was no medically treated arm in this study.
29 Aug, 2021 | 18:06h | UTC
Commentary on Twitter
#ACST-2 stent CAS 🆚surgery CEA
For asymptotic carotid stenosis >= 60%https://t.co/lyLBn8C8cv
🔺No difference in death 30d MI, stroke 5 yr f/u
🔺Slight ⬆️in minor 30d strokes w Stenting but no QOL change at 6 mo
🔺no medical Rx arm
🔺both arms 1% procedural risk #ESCCongress pic.twitter.com/8ptcrstn0D— Ritu Thamman MD (@iamritu) August 29, 2021
#ESCCongress – RCT: Small benefit from systematic screening for atrial fibrillation in older adults – After a median follow-up of 6.9 y there were fewer events (stroke, embolism, bleeding, and death) in the intervention group (31·9%) vs. control group (33·0%).
29 Aug, 2021 | 18:08h | UTCClinical outcomes in systematic screening for atrial fibrillation (STROKESTOP): a multicentre, parallel group, unmasked, randomised controlled trial – The Lancet (link to abstract – $ for full-text)
News release: Screening for atrial fibrillation could reduce risk of stroke – Karolinska Institutet
#ESCCongress – RCT: In patients with heart failure, hemodynamic-guided management was not associated with improved outcomes.
29 Aug, 2021 | 18:03h | UTCHaemodynamic-guided management of heart failure (GUIDE-HF): a randomised controlled trial – The Lancet (free registration required)
Commentary:
Haemodynamic-GUIDEed management of Heart Failure – GUIDE-HF – American College of Cardiology
Commentary on Twitter
The GUIDE-HF trial showed hemodynamic-guided management using remote pulmonary artery pressure monitoring didn't ⬇️ mortality & total #heartfailure events in patients regardless of HF symptom severity compared w/ patients receiving usual care: https://t.co/15Iv1N78sJ #ESCCongress pic.twitter.com/rZSNCfw4kq
— American College of Cardiology (@ACCinTouch) August 27, 2021
#ESCCongress – Pilot study in Sweden showed drones delivered defibrillators faster than ambulances to patients with suspected cardiac arrest.
29 Aug, 2021 | 18:02h | UTCEditorial: Automated external defibrillator delivery by drones: are we ready for prime time?
News releases:
Drones delivered defibrillators to patients with suspected cardiac arrests – Karolinska Institutet
Commentary on Twitter
Just released: #drones are effective in successfully delivering #AEDs to patients with suspected out-of-hospital cardiac arrest #OHCA, with a time benefit compared to emergency medical services https://t.co/D9XOI0Pep4 #EHJ #ESCcongress #ESCYoung @ehj_ed @rladeiraslopes pic.twitter.com/oRSMdQVqAC
— European Society of Cardiology Journals (@ESC_Journals) August 27, 2021
It’s not just SARS-CoV-2: Most respiratory viruses spread by aerosols.
27 Aug, 2021 | 10:18h | UTCOriginal article: Airborne transmission of respiratory viruses – Science
Commentary on Twitter (thread – click for more)
1/ AIRBORNE TRANSMISSION OF RESPIRATORY VIRUSES
A new peer-reviewed paper in @ScienceMagazine, reviewing the scientific literature on this topic. We conclude it is important not just for COVID-19, but also for other respiratory diseases such as the fluhttps://t.co/vik1deBzeB
— Prof. Jose-Luis Jimenez (@jljcolorado) August 26, 2021
#ESCCongress [not published yet] – Systematic FFR has no additional benefit at diagnostic angiography in patients with chest pain.
29 Aug, 2021 | 18:00h | UTCPress release: Systematic pressure wire assessment has no additional benefit at diagnostic angiography – European Society of Cardiology
Commentaries:
FFR During Angiogram Not Beneficial in Chest Pain Patients: RIPCORD 2 – TCTMD
Related:
Randomized Trial: Five-Year Outcomes with PCI Guided by FFR
[Press release – not published yet] Study shows vaccine protection wanes over time, but vaccines still offer good protection against severe disease.
27 Aug, 2021 | 10:11h | UTCPress release: Is COVID vaccine protection fading? – ZOE Covid Study
Commentaries:
Covid infection protection waning in double jabbed – BBC
Cohort study: Most COVID-19 hospital survivors had a good physical and functional recovery after 1 year of follow-up, but around half of the patients had at least one sequelae symptom.
27 Aug, 2021 | 10:13h | UTC1-year outcomes in hospital survivors with COVID-19: a longitudinal cohort study – The Lancet
Editorial: Understanding long COVID: a modern medical challenge – The Lancet
Related:
M-A: More than 50 long-term effects of COVID-19. (several articles on the subject)
New guidelines to help doctors manage long COVID patients published.
[Preprint] Observational data suggests natural immunity after a SARS-CoV-2 infection confers longer lasting and stronger protection compared to vaccine-induced immunity.
27 Aug, 2021 | 10:16h | UTC
Commentary on Twitter (thread – click for more)
https://twitter.com/andrew_croxford/status/1430799815693250562
Editorial: The Guardian view on global vaccine inequality: unwise as well as unethical.
27 Aug, 2021 | 10:09h | UTCThe Guardian view on global vaccine inequality: unwise as well as unethical
Covid-19 vaccines flirted with perfection at first. Reality is more complicated.
27 Aug, 2021 | 10:05h | UTCCovid-19 vaccines flirted with perfection at first. Reality is more complicated – STAT
Commentary on Twitter
The mixed blessing of the 95% VE: When Pfizer & Moderna reported late last year that their Covid vaccines were highly effective, our expectations for these vaccines soared. It's time for us to get more realistic about what the vaccines can do. https://t.co/BFpje2qRmS
— Helen Branswell 🇨🇦 (@HelenBranswell) August 25, 2021
mRNA vaccines for infectious diseases: principles, delivery and clinical translation.
27 Aug, 2021 | 10:03h | UTC
Commentary on Twitter
It took over 3 decades for mRNA vaccines to be developed. Now their potential against Covid variants and other pathogens is limitless. An outstanding new review @NatRevDrugDisc https://t.co/HETmUVru0Q @WeissmanLab @KWhiteheadLab pic.twitter.com/dN0jgsrEh3
— Eric Topol (@EricTopol) August 27, 2021


